2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Methyldopa: new trials by email Literature Review of Methyldopa trials Research Report on Methyldopa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations BF-Methyldopa 250mg Tablet, Metopa Tab 250mg - Healthy | Phase 1 | Completed | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | 17 | 2017-09-20 | 2018-01-18 |
| Autonomic Nervous System and Chronic Fatigue Syndrome Autonomic Function Testing, Saline infusions, L-NMMA trimethaphan - Chronic Fatigue Syndrome, Orthostatic Intolerance | Phase 1 | Completed | Vanderbilt University | 170 | 2007-04-01 | 2017-01-18 |
| Treatment Targets for Chronic Hypertension in Pregnancy methyldopa, labetalol, nifedipine - Pregnancy Toxemia, Hypertension | Phase 1 / Phase 2 | Withdrawn | Weill Medical College of Cornell University | 2004-07-01 | 2017-01-30 |
Fatigue Syndrome, Chronic (1) · Hypertension (1) · Orthostatic Intolerance (1) · Postural Orthostatic Tachycardia Syndrome (1) · Pre-Eclampsia (1) · Proteinuria (1) · Toxemia (1)
Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited (1) · Vanderbilt University (1) · Weill Medical College of Cornell University (1)
United States (2) · Hong Kong (1)
Brian Tomlinsion (1) · Italo Biaggioni, MD (1) · Phyllis August, MD MPH (1) · Riza Ozaki (1) · Zhong Zuo (1)